2492472-82-7
2492472-82-7
Chemical Structure
Camoteskimab
Synonym(s): AVTX-007; CERC-007; MEDI 2338
- CAS No.: 2492472-82-7
- Formula:N/A
- Molecular Weight:(146.34 kDa)
IUPAC Name: 2-nitrophen-3,4,5,6-d4-ol
SMILES: [Camoteskimab]
Biological Activity: Camoteskimab is a fully human monoclonal antibody with high affinity targeting IL-18. Camoteskimab is applicable to the research of autoinflammatory diseases[1][2][3][4].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Camoteskimab | 98.56% | Camoteskimab is a fully human monoclonal antibody with high affinity targeting IL-18. Camoteskimab is applicable to the research of autoinflammatory diseases. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Bindoli S, et al. Adult-Onset Still's Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options. Drugs. 2024;84(3):257-274. [Content Brief]
- [2]. Chen X, et al. Identification of cross-talk pathways and PANoptosis-related genes in periodontitis and Alzheimer's disease by bioinformatics analysis and machine learning. Front Aging Neurosci. 2024 Aug 27;16:1430290. [Content Brief]
- [3]. Richard Brown, et al. Anti-il-18 antibody therapy for treating atopic dermatitis. WO2024261470A1. 2025-12-20.
- [4]. Galozzi P, et al. Progress in Biological Therapies for Adult-Onset Still's Disease. Biologics. 2022;16:21-34. Published 2022 Apr 21. [Content Brief]
